Cardio IQ Advanced Lipid Panel CARDIOIQ

Synonyms
Allscripts (AEHR) Order Name	Cardio IQ Advanced Lipid Panel
Sunrise Clinical Manager (SCM) Order Name	Cardio IQ Advanced Lipid Panel
EPIC Order Name	Cardio IQ Advanced Lipid Panel
Clinical Info	The advanced lipid profile provides a more comprehensive assessment of dyslipidemia and cardiovascular risk than standard lipid panel measurements
Specimen Type	Blood
Container	Gold Top Tube
Collection Instructions	Container/Tube: Gold top tube Specimen: 4 mL serum (2 ml min) Collection Instructions The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been...determined to interfere with assays for... Cholesterol, Uric Acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours. Patient Preparation If a Cholesterol measurement is to be performed along with Triglycerides, but not part of a Lipid Panel, then the patient should be fasting 9-12 hours prior to collection. If the Cholesterol is ordered as part of a Lipid Panel, then a fasting sample is not required.
Transport Instructions	Refrigerated
Specimen Stability	Room temperature: 24 hours Refrigerated: 7 days Frozen: 15 days
Methodology	Enzymatic • Nephelometry • Immunoturbidometric • Ion Mobility • Spectrophotometry (SP) Includes: Cardio IQ® Cholesterol, Total; Cardio IQ® HDL Cholesterol; Cardio IQ® Triglycerides; Cardio IQ® Non-HDL and Calculated Components; Cardio IQ® Lipoprotein Fractionation, Ion Mobility; Cardio IQ® Apolipoprotein B; Cardio IQ® Lipoprotein (a) If Triglyceride is >400 mg/dL, then Cardio IQ® Direct LDL will be performed at an additional charge
Days Performed	Monday - Friday TAT: 5 - 8 Days
Performing Laboratory	Quest Diagnostics' Nichols Institute, Inc. - Chantilly
CPT	80061 83704 82172 83695
PDM	1759390
Result Interpretation See Laboratory Report This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Forms